1. Home
  2. KRMD vs DERM Comparison

KRMD vs DERM Comparison

Compare KRMD & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$3.40

Market Cap

192.5M

Sector

Health Care

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$6.72

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
DERM
Founded
1980
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.5M
190.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRMD
DERM
Price
$3.40
$6.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$6.50
$12.67
AVG Volume (30 Days)
229.6K
190.6K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
34.72
EPS
N/A
N/A
Revenue
$41,127,366.00
$61,858,000.00
Revenue This Year
$20.32
$39.72
Revenue Next Year
$17.37
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
22.23
10.20
52 Week Low
$3.21
$4.31
52 Week High
$6.61
$9.56

Technical Indicators

Market Signals
Indicator
KRMD
DERM
Relative Strength Index (RSI) 32.01 49.92
Support Level $3.21 $6.54
Resistance Level $4.27 $6.59
Average True Range (ATR) 0.22 0.36
MACD -0.07 0.01
Stochastic Oscillator 12.72 26.67

Price Performance

Historical Comparison
KRMD
DERM

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: